Cited by 1,973Cancer Cells and MetastasisBreast Cancer Treatment Studies3D Printing in Biomedical Research

The DOI matches its Crossref record; 75 of the 79 references it cites were found in a registry or an index.

A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity

Open access

Sachs, Norman, de Ligt, Joep, Kopper, Oded, Gogola, Ewa, Bounova, Gergana, Weeber, Fleur, Balgobind, Anjali Vanita, Wind, Karin, Gracanin, Ana, Begthel, Harry, Korving, Jeroen, van Boxtel, Ruben, Duarte, Alexandra Alves, Lelieveld, Daphne, van Hoeck, Arne, Ernst, Robert Frans, Blokzijl, Francis, Nijman, Isaac Johannes, Hoogstraat, Marlous, van de Ven, Marieke, Egan, David Anthony, Zinzalla, Vittoria, Moll, Jurgen, Boj, Sylvia Fernandez, Voest, Emile Eugene, Wessels, Lodewyk, van Diest, Paul Joannes, Rottenberg, Sven, Vries, Robert Gerhardus Jacob, Cuppen, Edwin, Clevers, Hans·2018·Cell

DOI 10.1016/j.cell.2017.11.010

Open this paper in CoChat — free account Open PDF

Abstract

Breast cancer (BC) comprises multiple distinct subtypes that differ genetically, pathologically, and clinically. Here, we describe a robust protocol for long-term culturing of human mammary epithelial organoids. Using this protocol, >100 primary and metastatic BC organoid lines were generated, broadly recapitulating the diversity of the disease. BC organoid morphologies typically matched the histopathology, hormone receptor status, and HER2 status of the original tumor. DNA copy number variations as well as sequence changes were consistent within tumor-organoid pairs and largely retained even after extended passaging. BC organoids furthermore populated all major gene-expression-based classification groups and allowed in vitro drug screens that were consistent with in vivo xeno-transplantations and patient response. This study describes a representative collection of well-characterized BC organoids available for cancer research and drug development, as well as a strategy to assess in vitro drug response in a personalized fashion.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2017.11.010

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w 1118 ; iso-2; iso-3
Cingolani, P., Platts, A., Wang, L. L., Coon, M., Nguyen, T., Wang, L., Land, S. J., Lu, X., & Ruden, D. M. (2012) · Fly · doi:10.4161/fly.19695 · Cited by 11,816
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
dbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502

Flagged first, then by citations

Show all 79 references

4 of the 79 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Blokzijl, 2016, MutationalPatterns: an integrative R package for studying patterns in base substitution catalogues, bioRxiv

Sorted by citations

Items 201–300 of 1,002

CRISPR screens decode cancer cell pathways that trigger γδ T cell detection
Mamedov, M. R., Vedova, S., Freimer, J. W., Sahu, A. D., Ramesh, A., Arce, M. M., Meringa, A. D., Ota, M., Chen, P. A., Hanspers, K., et al. (2023) · Nature · doi:10.1038/s41586-023-06482-x · Cited by 102
Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy
Klein, E., Hau, A., Oudin, A., Golebiewska, A., & Niclou, S. P. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.604121 · Cited by 102
Comprehensive analysis of structural variants in breast cancer genomes using single-molecule sequencingPreprint
Aganezov, S. S., Goodwin, S., Sherman, R. M., Sedlazeck, F. J., Arun, G., Bhatia, S., Lee, I., Kirsche, M., Wappel, R. L., Kramer, M., et al. (2020) · Genome Research · doi:10.1101/gr.260497.119 · Cited by 104
Organoids in image-based phenotypic chemical screens
Lukonin, I., Zinner, M., & Liberali, P. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00641-8 · Cited by 99
Nicotinamide Promotes Cell Survival and Differentiation as Kinase Inhibitor in Human Pluripotent Stem Cells
Meng, Y., Ren, Z., Xu, F., Zhou, X., Song, C., Wang, V. Y., Liu, W., Lu, L., Thomson, J. A., & Chen, G. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.10.023 · Cited by 100
Mimicking tumor hypoxia and tumor-immune interactions employing three-dimensional in vitro models
Bhattacharya, S., Calar, K., & de la Puente, P. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01583-1 · Cited by 106
Advanced 3D imaging and organoid bioprinting for biomedical research and therapeutic applications
Maharjan, S., Ma, C., Singh, B., Kang, H., Orive, G., Yao, J., & Zhang, Y. S. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115237 · Cited by 107
Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer
Wang, H., Xiang, D., Liu, B., He, A., Randle, H. J., Zhang, K. X., Dongre, A., Sachs, N., Clark, A. P., Tao, L., et al. (2019) · Cell · doi:10.1016/j.cell.2019.06.002 · Cited by 102
Self-citation
Organoids: a novel modality in disease modeling
Heydari, Z., Moeinvaziri, F., Agarwal, T., Pooyan, P., Shpichka, A. I., Maiti, T. K., Timashev, P. S., Baharvand, H., & Vosough, M. (2021) · Bio-Design and Manufacturing · doi:10.1007/s42242-021-00150-7 · Cited by 106
Patient-derived organoids in translational oncology and drug screening
Yang, R., & Yu, Y. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216180 · Cited by 99
Pregnancy and Breast Cancer: Pathways to Understand Risk and Prevention
Slepicka, P. F., Cyrill, S. L., & dos Santos, C. O. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.06.003 · Cited by 105
MaTAR25 lncRNA regulates the Tensin1 gene to impact breast cancer progression
Chang, K.-C., Diermeier, S. D., Yu, A. T., Brine, L., Russo, S., Bhatia, S., Alsudani, H., Kostroff, K. M., Bhuiya, T. A., Brogi, E., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20207-y · Cited by 98
The Use of Stem Cell-Derived Organoids in Disease Modeling: An Update
Azar, J. H., Bahmad, H. F., Daher, D., Moubarak, M. M., Hadadeh, O., Monzer, A., Bitar, S. A., Jamal, M., Al‐Sayegh, M., & Abou-Kheir, W. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147667 · Cited by 106
m5C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer malignancy through facilitating RABL6/TK1 mRNAs splicing and stabilization
Wang, N., Chen, R., Deng, M.-H., Wei, W., Zhou, Z., Kang, N., Li, Y., Li, X., Ye, Y., Wen, J.-H., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05661-y · Cited by 99
Airway organoids as models of human disease
van der Vaart, J., & Clevers, H. C. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13075 · Cited by 101
Self-citation
Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics
Ding, R., Chen, P., Rajendran, B. K., Lyu, X., Wang, H., Bao, J., Zeng, J., Hao, W., Sun, H., Wong, A. H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23379-3 · Cited by 97
Patient-derived organoids: a promising model for personalized cancer treatment
Yang, H., Sun, L., Liu, M., & Mao, Y. (2018) · Gastroenterology report · doi:10.1093/gastro/goy040 · Cited by 97
Microfluidic Organoids-on-a-Chip: Quantum Leap in Cancer Research
Düzağaç, F., Saorin, G., Memeo, L., Canzonieri, V., & Rizzolio, F. (2021) · Cancers · doi:10.3390/cancers13040737 · Cited by 97
Breast Cancer Heterogeneity
Fumagalli, C., & Barberis, M. C. P. (2021) · Diagnostics · doi:10.3390/diagnostics11091555 · Cited by 97
iPSC-derived and Patient-Derived Organoids: Applications and challenges in scalability and reproducibility as pre-clinical models
Heinzelmann, E., Piraino, F., Costa, M., Roch, A., Norkin, M. N., Garnier, V., Homicskó, K., & Brandenberg, N. (2024) · Current Research in Toxicology · doi:10.1016/j.crtox.2024.100197 · Cited by 107
A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity
Nelson, L., Tighe, A., Golder, A., Littler, S., Bakker, B., Moralli, D., Baker, S. M., Donaldson, I. J., Spierings, D. C. J., Wardenaar, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14551-2 · Cited by 97
Salivary gland organoid culture maintains distinct glandular properties of murine and human major salivary glands
Yoon, Y., Kim, D., Tak, K. Y., Hwang, S., Kim, J., Sim, N. S., Cho, J.-M., Choi, D., Ji, Y., Hur, J. K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30934-z · Cited by 108
Targeting polyploid giant cancer cells potentiates a therapeutic response and overcomes resistance to PARP inhibitors in ovarian cancer
Zhang, X., Yao, J., Li, X., Niu, N., Liu, Y., Hajek, R. A., Peng, G., Westin, S. N., Sood, A. K., & Liu, J. (2023) · Science Advances · doi:10.1126/sciadv.adf7195 · Cited by 101
Synthetic scaffolds for 3D cell cultures and organoids: applications in regenerative medicine
Marchini, A., & Gelain, F. (2022) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2021.1932716 · Cited by 91
Characterization of drug responses of mini patient‐derived xenografts in mice for predicting cancer patient clinical therapeutic response
Zhang, F., Wang, W., Long, Y., Liu, H., Cheng, J., Guo, L., Li, R., Meng, C., Yu, S., Zhao, Q., et al. (2018) · 癌症：英文版 · doi:10.1186/s40880-018-0329-5 · Cited by 94
Nerves and Pancreatic Cancer: New Insights into A Dangerous Relationship
Gasparini, G., Pellegatta, M., Crippa, S., Lena, M. S., Belfiori, G., Doglioni, C., Taveggia, C., & Falconi, M. (2019) · Cancers · doi:10.3390/cancers11070893 · Cited by 92
Methodological aspects and pharmacological applications of three-dimensional cancer cell cultures and organoids
Foglietta, F., Canaparo, R., Muccioli, G., Terreno, E., & Serpe, L. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117784 · Cited by 101
Biobanks—A Platform for Scientific and Biomedical Research
Malsagova, K. A., Kopylov, A. T., Stepanov, A. A., Butkova, T. V., Sinitsyna, A. A., Izotov, A., & Kaysheva, A. L. (2020) · Diagnostics · doi:10.3390/diagnostics10070485 · Cited by 96
Organoid engineering with microfluidics and biomaterials for liver, lung disease, and cancer modeling
Kim, S. K., Kim, Y. H., Park, S., & Cho, S. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.002 · Cited by 96
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
Jiang, Y., Ma, D., Jin, X., Xiao, Y., Yu, Y., Shi, J., Zhou, Y.-F., Fu, T., Lin, C., Dai, L.-J., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00725-0 · Cited by 109
Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine
Yao, Q., Cheng, S., Pan, Q., Yu, J., Cao, G., Li, L., & Cao, H. (2024) · MedComm · doi:10.1002/mco2.735 · Cited by 100
Generation and Characterization of Patient‐Derived Head and Neck, Oral, and Esophageal Cancer Organoids
Karakasheva, T. A., Kijima, T., Shimonosono, M., Maekawa, H., Sahu, V., Gabre, J. T., Cruz‐Acuña, R., Giroux, V., Sangwan, V., Whelan, K. A., et al. (2020) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.109 · Cited by 92
Breast Cancer Organoids Model Patient-Specific Response to Drug Treatment
Campaner, E., Zannini, A., Santorsola, M., Bonazza, D., Bottin, C., Cancila, V., Tripodo, C., Bortul, M., Zanconati, F., Schoeftner, S., et al. (2020) · Cancers · doi:10.3390/cancers12123869 · Cited by 97
eDNA in subterranean ecosystems: Applications, technical aspects, and future prospects
Saccò, M., Guzik, M. T., van der Heyde, M., Nevill, P., Cooper, S. J., Austin, A. D., Coates, P. J., Allentoft, M. E., & White, N. E. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.153223 · Cited by 99
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
Foo, M. A., You, M., Chan, S. L., Sethi, G., Bonney, G. K., Yong, W. P., Chow, E. K., Fong, E. L. S., Wang, L., & Goh, B.-C. (2022) · Biomarker Research · doi:10.1186/s40364-022-00356-6 · Cited by 100
3D cancer models: One step closer to in vitro human studies
Manduca, N., Maccafeo, E., Maria, R. D., Sistigu, A., & Musella, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1175503 · Cited by 103
Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development
Majc, B., Novak, M., Kopitar‐Jerala, N., Jewett, A., & Breznik, B. (2021) · Cells · doi:10.3390/cells10020265 · Cited by 98
Mammary Tumor Organoid Culture in Non‐Adhesive Alginate for Luminal Mechanics and High‐Throughput Drug Screening
Fang, G., Lu, H., de la Fuente, L. R., Law, A. M. K., Lin, G., Jin, D., & Gallego‐Ortega, D. (2021) · Advanced Science · doi:10.1002/advs.202102418 · Cited by 91
Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine
Derouane, F., van Marcke, C., Berlière, M., Gerday, A., Fellah, L., Leconte, I., Bockstal, M. V., Galant, C., Corbet, C., & Duhoux, F. P. (2022) · Cancers · doi:10.3390/cancers14163876 · Cited by 93
Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine
Qu, S., Xu, R., Yi, G., Li, Z., Zhang, H., Qi, S., & Huang, G. (2024) · Molecular Biomedicine · doi:10.1186/s43556-023-00165-9 · Cited by 106
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities
Cosgrove, N. S., Varešlija, D., Keelan, S., Elangovan, A., Atkinson, J. M., Cocchiglia, S., Bane, F. T., Singh, V., Furney, S. J., Hu, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-27987-5 · Cited by 92
Past, Present, and Future of Brain Organoid Technology.
Koo, B., Choi, B., Park, H., & Yoon, K. (2019) · Europe PMC (PubMed Central) · doi:10.14348/molcells.2019.0162 · Cited by 93
Black Phosphorus Quantum Dots Cause Nephrotoxicity in Organoids, Mice, and Human Cells
He, C., Ruan, F., Jiang, S., Zeng, J., Yin, H., Liu, R., Zhang, Y., Huang, L., Wang, C., Ma, S., et al. (2020) · Small · doi:10.1002/smll.202001371 · Cited by 90
LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer
Jin, X., Ge, L., Li, D., Shao, Z., Di, G. H., Xu, X., & Jiang, Y. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01210-9 · Cited by 91
Orthotopic and metastatic tumour models in preclinical cancer research
Stribbling, S. M., Beach, C., & Ryan, A. J. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108631 · Cited by 101
Replacement, Reduction, and Refinement of Animal Experiments in Anticancer Drug Development: The Contribution of 3D In Vitro Cancer Models in the Drug Efficacy Assessment
Tosca, E. M., Ronchi, D., Facciolo, D., & Magni, P. (2023) · Biomedicines · doi:10.3390/biomedicines11041058 · Cited by 95
Assessing Toxicity with Human Cell-Based In Vitro Methods
Zink, D., Chuah, J. K. C., & Ying, J. Y. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.01.008 · Cited by 87
“Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction”
Papaccio, F., García-Micó, B., Gimeno-Valiente, F., Cabeza-Segura, M., Gambardella, V., Gutiérrez-Bravo, M. F., Alfaro‐Cervelló, C., Martínez‐Ciarpaglini, C., Rentero-Garrido, P., Zúñiga, S., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02591-z · Cited by 91
Multiplexed drug testing of tumor slices using a microfluidic platform
Horowitz, L. F., Rodriguez, A. D., Dereli-Korkut, Z., Lin, R., Castro, K., Mikheev, A. M., Monnat, R. J., Folch, A., & Rostomily, R. C. (2020) · npj Precision Oncology · doi:10.1038/s41698-020-0117-y · Cited by 88
Bacterial cellulose based composites enhanced transdermal drug targeting for breast cancer treatment
Zhang, L., Du, S., Wang, X., Jiao, Y., Yin, L., Zhang, Y., & Guan, Y. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.03.216 · Cited by 87
Current Status of Patient-Derived Ovarian Cancer Models
Maru, Y., & Hippo, Y. (2019) · Cells · doi:10.3390/cells8050505 · Cited by 92
3D bioprinted vascularized lung cancer organoid models with underlying disease capable of more precise drug evaluation
Choi, Y.-M., Lee, H., Ann, M., Song, M., Rheey, J., & Jang, J. (2023) · Biofabrication · doi:10.1088/1758-5090/acd95f · Cited by 94
Organoid Models for Precision Cancer Immunotherapy
Sun, C., Lan, H., Fang, X., Yang, X., & Jin, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.770465 · Cited by 90
Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites
Dayton, T. L., Alcala, N., Moonen, L., den Hartigh, L., Geurts, V., Mangiante, L., Lap, L. M. V., Dost, A. F. M., Beumer, J., Levy, S., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.11.007 · Cited by 89
Self-citation
Breakthroughs and challenges of organoid models for assessing cancer immunotherapy: a cutting-edge tool for advancing personalised treatments
Wang, Q., Yuan, F., Zuo, X., & Li, M. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02505-w · Cited by 101
Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges
Wang, D., Villenave, R., Stokar‐Regenscheit, N., & Clevers, H. C. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01317-y · Cited by 111
Self-citation
Establishment and Morphological Characterization of Patient-Derived Organoids from Breast Cancer
Mazzucchelli, S., Piccotti, F., Allevi, R., Truffi, M., Sorrentino, L., Russo, L., Agozzino, M., Signati, L., Bonizzi, A., Villani, L., et al. (2019) · Biological Procedures Online · doi:10.1186/s12575-019-0099-8 · Cited by 85
90 YEARS OF PROGESTERONE: Progesterone and progesterone receptors in breast cancer: past, present, future
Horwitz, K. B., & Sartorius, C. A. (2020) · Journal of Molecular Endocrinology · doi:10.1530/jme-20-0104 · Cited by 85
Organoids and organs-on-chips: insights into predicting the efficacy of systemic treatment in colorectal cancer
Zhu, J., Ji, L., Chen, Y., Li, H., Huang, M., Dai, Z., Wang, J., Xiang, D., Fu, G., Lei, Z., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01354-9 · Cited by 92
Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks
Palechor-Ceron, N., Krawczyk, E., Dakic, A., Simić, V., Yuan, H., Blancato, J. K., Wang, W., Hubbard, F. A., Zheng, Y., Dan, H., et al. (2019) · Cells · doi:10.3390/cells8111327 · Cited by 80
Prostate cancer patient‐derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens
Servant, R., Garioni, M., Vlajnic, T., Blind, M., Pueschel, H., Müller, D. C., Zellweger, T., Templeton, A. J., Garofoli, A., Maletti, S., et al. (2021) · The Journal of Pathology · doi:10.1002/path.5698 · Cited by 82
A pancreatic cancer organoid platform identifies an inhibitor specific to mutant KRAS
Duan, X., Zhang, T., Feng, L., de Silva, N., Greenspun, B. C., Wang, X., Moyer, J. E., Martin, M. L., Chandwani, R., Elemento, O., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.11.011 · Cited by 85
Spatial Transcriptomics: A Powerful Tool in Disease Understanding and Drug Discovery
Cao, J., Li, C., Cui, Z., Deng, S., Tong, L., Liu, W., Yang, H., & Chen, P. (2024) · Theranostics · doi:10.7150/thno.95908 · Cited by 91
Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function
Groot, K. M. D. W., Janssens, H. M., van Uum, R. T., Dekkers, J. F., Berkers, G., Vonk, A. M., Kruisselbrink, E., Oppelaar, H., Vries, R. G. J., Clevers, H. C., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.02529-2017 · Cited by 80
Self-citation
Integrated cancer tissue engineering models for precision medicine
Bregenzer, M. E., Horst, E. N., Mehta, P., Novak, C. M., Raghavan, S. A., Snyder, C. S., & Mehta, G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216564 · Cited by 84
Microvascularized tumor organoids-on-chips: advancing preclinical drug screening with pathophysiological relevance
Lim, J., Ching, H., Yoon, J., Jeon, N. L., & Kim, Y. (2021) · Nano Convergence · doi:10.1186/s40580-021-00261-y · Cited by 85
Untangling the web of intratumour heterogeneity
Li, Z., Seehawer, M., & Polyák, K. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00969-x · Cited by 82
Role of Patient-Derived Models of Cancer in Translational Oncology
Idrisova, K., Simon, H., & Gomzikova, M. O. (2022) · Cancers · doi:10.3390/cancers15010139 · Cited by 84
Organoid bioprinting: from cells to functional tissues
Huang, M. S., Christakopoulos, F., Roth, J. G., & Heilshorn, S. C. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00268-0 · Cited by 99
Zebrafish Avatars towards Personalized Medicine—A Comparative Review between Avatar Models
Costa, B. F., Estrada, M. F., Mendes, R. V., & Fior, R. (2020) · Cells · doi:10.3390/cells9020293 · Cited by 87
Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label therapy
Hirt, C., Booij, T. H., Grob, L., Simmler, P., Toussaint, N. C., Keller, D., Taube, D., Ludwig, V., Goryachkin, A., Pauli, C., et al. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100095 · Cited by 92
CRISPR–Cas9 Gene Editing: Curing Genetic Diseases by Inherited Epigenetic Modifications
Kolanu, N. D. (2024) · Global Medical Genetics · doi:10.1055/s-0044-1785234 · Cited by 93
Bridging live-cell imaging and next-generation cancer treatment
Alieva, M., Wezenaar, A. K. L., Wehrens, E. J., & Rios, A. C. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00610-5 · Cited by 84
Organoid intelligence: Integration of organoid technology and artificial intelligence in the new era of in vitro models
Shi, H., Kowalczewski, A. C., Vu, D., Liu, X., Salekin, A., Yang, H., & Ma, Z. (2023) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2023.100276 · Cited by 90
Construction of tumor organoids and their application to cancer research and therapy
Lv, J., Du, X., Wang, M., Su, J., Wei, Y., & Xu, C. (2024) · Theranostics · doi:10.7150/thno.91362 · Cited by 90
Patient‐derived organoids for personalized gallbladder cancer modelling and drug screening
Yuan, B., Zhao, X., Wang, X., Liu, E., Liu, C., Zong, Y., Jiang, Y., Hou, M., Chen, Y., Chen, L., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.678 · Cited by 81
Applications of human organoids in the personalized treatment for digestive diseases
Wang, Q., Guo, F., Jin, Y., & Ma, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01194-6 · Cited by 87
A reproducible scaffold-free 3D organoid model to study neoplastic progression in breast cancer
Djomehri, S. I., Burman, B., González, M. E., Takayama, S., & Kleer, C. G. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-018-0498-7 · Cited by 79
Aptamer based recognition of cancer cells: Recent progress and challenges in bioanalysis
Kordasht, H. K., & Hasanzadeh, M. (2020) · Talanta · doi:10.1016/j.talanta.2020.121436 · Cited by 78
3D modeling in cancer studies
Atat, O. E., Farzaneh, Z., Pourhamzeh, M., Taki, F., Abi‐Habib, R. J., Vosough, M., & El‐Sibai, M. (2021) · Human Cell · doi:10.1007/s13577-021-00642-9 · Cited by 83
Stem cells in tissues, organoids, and cancers
Wang, X. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03199-x · Cited by 80
Executable cancer models: successes and challenges
Clarke, M. A., & Fisher, J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0258-x · Cited by 81
Druggable genome and precision medicine in cancer: current challenges
Dupont, C., Riegel, K., Pompaiah, M., Juhl, H. H., & Rajalingam, K. (2021) · FEBS Journal · doi:10.1111/febs.15788 · Cited by 83
Enabling peristalsis of human colon tumor organoids on microfluidic chips
Fang, G., Lu, H., Al-Nakashli, R., Chapman, R., Zhang, Y., Ju, L. A., Lin, G., Stenzel, M. H., & Jin, D. (2022) · Biofabrication · doi:10.1088/1758-5090/ac2ef9 · Cited by 77
Immune organoids: from tumor modeling to precision oncology
Dao, V. A., Yuki, K., Lo, Y., Nakano, M., & Kuo, C. J. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.06.001 · Cited by 80
A microfluidic platform for functional testing of cancer drugs on intact tumor slices
Rodriguez, A. D., Horowitz, L. F., Castro, K., Kenerson, H., Bhattacharjee, N., Gandhe, G., Raman, A., Monnat, R. J., Yeung, R., Rostomily, R. C., et al. (2020) · Lab on a Chip · doi:10.1039/c9lc00811j · Cited by 77
Prostate Stem Cells and Cancer Stem CellsPreprint
Li, J. J., & Shen, M. M. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030395 · Cited by 80
Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients
Chen, J., Chu, X., Zhang, J., Nie, Q., Tang, W., Su, J., Yan, H., Zheng, H., Chen, Z., Chen, X., et al. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13542 · Cited by 78
Cellular Metabolic Heterogeneity In Vivo Is Recapitulated in Tumor Organoids
Sharick, J. T., Jeffery, J. J., Karim, M. R., Walsh, C. M., Esbona, K., Cook, R. S., & Skala, M. C. (2019) · Neoplasia · doi:10.1016/j.neo.2019.04.004 · Cited by 71
Organoid technology for tissue engineering
He, J., Zhang, X., Xia, X., Han, M., Li, F., Li, C., Li, Y., & Gao, D. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa012 · Cited by 78
Harnessing 3D in vitro systems to model immune responses to solid tumours: a step towards improving and creating personalized immunotherapies
Zhou, Z., Pang, Y., Ji, J., He, J., Liu, T., Ouyang, L., Zhang, W., Zhang, X., Zhang, Z., Zhang, K., et al. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00896-4 · Cited by 79
3D tumor cultures for drug resistance and screening development in clinical applications
Peng, Z., Lv, X., Sun, H., Zhao, L., & Huang, S. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02281-2 · Cited by 77
From 2D to 3D and beyond: the evolution and impact of in vitro tumor models in cancer research
Rauner, G., Gupta, P. B., & Kuperwasser, C. (2025) · Nature Methods · doi:10.1038/s41592-025-02769-1 · Cited by 82
Translational research
Mahalmani, V., Sinha, S., Prakash, A., & Medhi, B. (2022) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_860_22 · Cited by 87
Drug screening model meets cancer organoid technology
Liu, C., Qin, T., Huang, Y., Li, Y., Chen, G., & Sun, C. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100840 · Cited by 75
Organoid Cultures Derived From Patients With Papillary Thyroid Cancer
Chen, D., Tan, Y., Li, Z., Li, W., Yu, L., Chen, W., Liu, Y., Liu, L., Guo, L., Huang, W., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab020 · Cited by 72
Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer
Francavilla, C., & O’Brien, C. (2022) · Open Biology · doi:10.1098/rsob.210373 · Cited by 74
Single-cell morphological and topological atlas reveals the ecosystem diversity of human breast cancer
Zhao, S., Chen, D.-P., Fu, T., Yang, J., Ma, D., Zhu, X.-Z., Wang, X.-X., Jiao, Y., Jin, X., Xiao, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42504-y · Cited by 79
Breast tumor-on-chip models: From disease modeling to personalized drug screening
Bano, S., Dahiya, U. R., Mishra, S., Ayache, J., Casquillas, G. V., Caballero, D., Reis, R. L., & Kundu, S. C. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.057 · Cited by 78
A three-dimensional organoid model recapitulates tumorigenic aspects and drug responses of advanced human retinoblastoma
Saengwimol, D., Rojanaporn, D., Chaitankar, V., Chittavanich, P., Aroonroch, R., Boontawon, T., Thammachote, W., Jinawath, N., Hongeng, S., & Kaewkhaw, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-34037-y · Cited by 75

Authors: Sachs, N., de Ligt, J., Kopper, O., Gogola, E., Bounova, G., Weeber, F., Balgobind, A. V., Wind, K., Gracanin, A., Begthel, H., Korving, J., van Boxtel, R., Duarte, A. A., Lelieveld, D., van Hoeck, A., Ernst, R. F., Blokzijl, F., Nijman, I. J., Hoogstraat, M., van de Ven, M., Egan, D. A., Zinzalla, V., Moll, J., Boj, S. F., Voest, E. E., Wessels, L., van Diest, P. J., Rottenberg, S., Vries, R. G. J., Cuppen, E., & Clevers, H.
Affiliations: Royal Netherlands Academy of Arts and Sciences (NL)
The Netherlands Cancer Institute (NL)
University Medical Center Utrecht (NL)
Utrecht University (NL)
Boehringer Ingelheim (Austria) (AT)
Oncode Institute (NL)
University of Bern (CH)
Corresponding author: Clevers, Hans
ORCID: Sachs, Norman
Gogola, Ewa
Weeber, Fleur
Begthel, Harry
Ernst, Robert Frans
Blokzijl, Francis
Hoogstraat, Marlous
Boj, Sylvia Fernandez
Voest, Emile Eugene
Wessels, Lodewyk
Rottenberg, Sven
Vries, Robert Gerhardus Jacob
Cuppen, Edwin
Clevers, Hans
Venue: Cell
Publisher: Elsevier BV
Published: 2018-01
Volume: 172
Issue: 1-2
Pages: 373-386.e10
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/j.cell.2017.11.010
OpenAlex: W2773981699
Cited by: 1,973
References: 79
Citations by year: 2026: 219 · 2025: 240 · 2024: 288 · 2023: 251 · 2022: 274 · 2021: 259 · 2020: 238 · 2019: 127 · 2018: 74
FWCI: 53.62
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 375 d)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Bern Open Repository and Information System (University of Bern) (submittedVersion)
Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (submittedVersion)
Utrecht University Repository (Utrecht University) (submittedVersion)
Funders: MKMD (114021012)
Netherlands Organization for Scientific Research (91615182, 114021012)
Stand Up to Cancer International Translational Cancer Research Grant
Stichting Vrienden van Hubrecht (2012.010)
Cancer Genomic Center (2014-186)
Boehringer-Ingelheim RCV GmbH & Co KG (141947)
Topics: Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
Keywords: breast cancer, organoid biobank, tumor heterogeneity, metastatic breast cancer, long-term organoid culture, copy number variation, gene expression subtypes, hormone receptor status, HER2 status, in vitro drug testing, xenotransplantation
MeSH terms: Animals, Antineoplastic Agents, Breast Neoplasms, Cells, Cultured, Drug Screening Assays, Antitumor, Female, Humans, Mice, Nude, Organoids, Tissue Banks, Genetic Heterogeneity, Mice, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks